Patent ID: 8871245

Claim:
A transdermal patch for treatment of Alzheimer's disease, comprising: a backing; a rivastigmine-containing layer provided on the backing; a pressure-sensitive adhesive layer provided on the rivastigmine-containing layer; and a release liner, or comprising: a backing; a pressure-sensitive adhesive layer provided on the backing; a rivastigmine-containing layer provided on the pressure-sensitive adhesive layer; and a release liner, wherein the rivastigmine-containing layer contains rivastigmine and an alkyl (meth)acrylate resin, the pressure-sensitive adhesive layer is composed of an acrylic pressure-sensitive adhesive containing a (meth)acrylic acid ester having a hydroxy group, wherein the pressure-sensitive adhesive layer does not contain an acrylic pressure-sensitive adhesive containing a (meth)acrylic acid ester having carboxy group, and neither the rivastigmine-containing layer nor the pressure-sensitive adhesive layer contains an anti-oxidizing agent.